Randomized Evaluation and Verification of Ventricular Enhancement

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 1, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Ischemic CardiomyopathyHeart Failure
Interventions
DEVICE

Revivent TC Ventricular Enhancement System

Anchors that are implanted into the left ventricle to reshape and reduce the size and increase the efficiency of the pumping chamber.

DRUG

GDMT

Guideline Directed Medical Therapy

Trial Locations (1)

13353

German Heart Institute Berlin and Charité University Medicine Berlin, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BioVentrix

INDUSTRY

NCT03845127 - Randomized Evaluation and Verification of Ventricular Enhancement | Biotech Hunter | Biotech Hunter